Literature DB >> 2862317

Atheroembolic renal disease causes hypocomplementaemia.

F G Cosio, R A Zager, H M Sharma.   

Abstract

7 patients with atheroembolic renal disease were found to have hypocomplementaemia. Evidence obtained in an experimental model of atheroembolic disease shows that the hypocomplementaemia is the result of complement activation by the atheromatous material in vivo. In addition to hypocomplementaemia, 6 patients had thrombocytopenia and 5 had eosinophilia. These observations indicate that atheroembolic disease should now be included in the differential diagnosis of hypocomplementaemia. In addition, atheroembolic disease should be considered in patients presenting with a combination of multisystem disease, hypocomplementaemia, thrombocytopenia, and eosinophilia--a syndrome which previously would have been regarded as diagnostic of immune-complex-mediated vasculitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862317     DOI: 10.1016/s0140-6736(85)90225-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

Review 1.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

2.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

Authors:  P S Seifert; G K Hansson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Progressive acute kidney injury following myocardial infarction: cholesterol embolisation.

Authors:  Malvinder S Parmar
Journal:  BMJ Case Rep       Date:  2009-02-23

4.  Cholesterol crystal embolisation to the alimentary tract.

Authors:  W Moolenaar; C B Lamers
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

5.  Cholestrol emboli syndrome: acute renal insufficiency after a procedure or a thrombolytic therapy or anticoagulant therapy.

Authors:  C Chandra Sekhar; Parveen Jindal; V Guru Karna; Manoj Aggarwala; Soma Sekhar
Journal:  Indian J Surg       Date:  2012-10-07       Impact factor: 0.656

Review 6.  Cholesterol Crystal Embolism and Chronic Kidney Disease.

Authors:  Xuezhu Li; George Bayliss; Shougang Zhuang
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

7.  Atheroembolic Renal Disease: A Case Series.

Authors:  K S Jansi Prema; Anila A Kurien
Journal:  Indian J Nephrol       Date:  2019 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.